Product Program year 2023 Source: CMS Open Payments

Infasurf

Drug Respiratory

Open in the dashboard

General payments

$44,362

36 payments

Research payments

$51,620

15 payments

Through program year 2023, $44,362 in general payments and $51,620 in research payments were reported against Infasurf (Respiratory).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2023 Research $17,000 6
2022 General $44,362 36
2022 Research $34,620 9

Breakdown

Who paid General payments · program year 2022
  1. ONY Biotech Inc. $44,362 36 payments
Top recipients General payments · program year 2022
  1. Scott Guthrie Neonatal-Perinatal Medicine · Nashville, TN $23,220 52% · 10 payments
  2. Kari Roberts Neonatal-Perinatal Medicine · Minneapolis, MN $12,842 29% · 7 payments
  3. Prem Fort Neonatal-Perinatal Medicine · St Petersburg, FL $6,434 15% · 4 payments
  4. Anup Katheria Pediatrics · San Diego, CA $340 <1% · 2 payments
  5. Dinushan Kaluarachchi Neonatal-Perinatal Medicine · Madison, WI $283 <1% · 2 payments

The top 5 of 16 recipients; each share is of general payments naming this product in 2022.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2022
  1. Neonatal-Perinatal Medicine Pediatrics $43,818 99% · 11 practitioners
  2. Pediatrics $421 <1% · 2 practitioners
  3. Pediatric Critical Care Medicine Pediatrics $97 <1% · 1 practitioner
  4. Nurse Practitioner, Neonatal Nurse Practitioner $26 <1% · 2 practitioners

Each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2022
  1. Tennessee $23,220 52% · 1 recipient
  2. Minnesota $12,842 29% · 1 recipient
  3. Florida $6,816 15% · 3 recipients
  4. California $340 <1% · 1 recipient
  5. New York $327 <1% · 3 recipients

The top 5 of 11 states; each share is of general payments naming this product in 2022 where a state was reported.

The top 25 states, free in the app

36 general · 15 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record